December 2021 Investment Summary

For our December 2021 Investment Summary, we take a closer look at the latest news and market trends we are seeing take place this month.

December began as November had ended with concerns over the new Omicron variant and how it would slow growth and exacerbate supply chain issues. The markets wrestled with how governments would respond, and how central banks would deal with persistently high levels of inflation that showed no signs of being transitory. In fact, the developed world experienced its highest levels of inflation in decades with the UK at 5.1%, US at 6.8%, the Eurozone at 4.9 %, with Germany in particular experiencing 5.2% for the year.

Despite these worries, equity markets rallied higher mid-December and closed 2021 strongly as the early evidence was that the new variant, whilst highly contagious, was less severe than earlier variants. In sterling terms, the Dow was up nearly 4% and the S&P 500 up just under 3% while the NASDAQ fell 0.6% for the month. In Europe, the story was similar with the Euro Stoxx 50 up over 4% and the FTSE 100 up just over 4.5%. Even Asian markets, which have struggled all year, managed to eke out small gains as the Nikkei 225 rose 0.4% and the Shanghai index was up over 1%.

For the full year, US indices were the place to be as the S&P 500 led the way with a 28.5% return in sterling terms, closely followed by the tech heavy NASDAQ up over 23% for the year. European and UK indices returned low teens while Asian markets struggled. The Nikkei 225 and the Hang Seng indices were both down on the year in sterling terms, while the Shanghai composite rose over 9%.

The same three issues we have discussed for much of the year (the pandemic, inflation and central banks response to inflation) continued to influence the direction of financial markets. Both the Federal Reserve and the Bank of England admitted that inflation was perhaps not as transitory as they had been thinking and that a change in policy was warranted.

The Federal Reserve announced they would rapidly reduce their pace of asset purchases, so that as of end of March of 2022 they would no longer be buying any US treasuries or mortgage-backed securities. They also forecast they would hike interest rates three times in 2022. The Bank of England chose to hike rates by 15 basis points and suggested they might hike rates a further three or four times in 2022. It is doubtful any of these actions will make a significant difference to inflation in the near term. Indeed, should inflation remain around current levels then central banks may be forced to act more boldly.

Financial markets may even take matters into their own hands if the central banks are viewed as too soft on inflation. Financial markets responded by pushing bond yields higher, particularly in the front part of the yield curve. More concerning or perhaps more damaging to investor psychology (and their wealth) has been the sharp sell-off in a variety of the more speculative tech names. This sell-off will likely persist until fixed income markets calm down.

While we doubt that the Federal Reserve or the Bank of England will hike more than they have currently forecast, it is not clear how fixed income markets will handle the sudden disappearance of their largest single buyer of duration. Since the advent of the pandemic in 2020, the Federal Reserve has purchased over $1.75 trillion in US treasuries. This has absorbed a huge chunk of the US government’s enormous deficit over that period. They also purchased another $800 billion+ in mortgage backed securities, taking additional duration out of the markets. The absence of this bond buying programme is likely to have an adverse effect on fixed income markets.

Turning to Covid-19, early data regarding the Omicron variant appears to show that the worst of the pandemic’s impact is waning. The new variant, while spreading more rapidly than was ever anticipated, is not bringing with it massive hospitalisations and deaths. Vaccines are working to limit critical illness and governments appear to be shifting to a stance where we learn to live with the virus rather than shut down activity in order to halt its spread.

China, in sharp contrast to the US and Europe, has not come to this conclusion and has locked down huge swathes of its economy in an attempt to eradicate the virus. These lockdowns will likely have an impact on global supply chains, resulting in continuing supply chain dislocations, shortages and price increases for many goods. It is not all bad news in China as they have been modestly easing monetary policy to mitigate the ongoing slowdown in their housing and property markets. We expect the People’s
Bank of China to continue to provide support, which should prevent a broad systematic financial collapse. That said, Chinese growth will continue to slow, and the world will notice.

Looking forward, we continue to favour equities with a preference for companies with earnings and pricing power. We recommend avoiding large holdings in “disruptive” firms with no earnings. Short duration within fixed income is still preferred, although any overshoot by financial markets may offer some opportunities later this year. Finally, watch out for central banks’ attempt to remove accommodation as this will likely result in a period of heightened volatility for financial markets.

Read more from our Chief Investment Officer Jeff Brummette in our November 2021 Investment Summary from last month. Stay tuned for more insights from Oakglen on the hot topics and latest trends in the financial markets. You can also sign up to our mailing list for more regular communications using the section below.

Jeff Brummette
Chief Investment Officer


This document is distributed by Oakglen Wealth Limited and / or Oakglen Wealth (Jersey) Limited (hereafter “Oakglen”) to you for your information and discussion only. Unless otherwise stated nothing in this document constitutes investment, legal, accounting, real estate, conveyancing, surveying or tax advice, or a representation that any investment is suitable or appropriate to your individual circumstances, or otherwise constitutes a personal recommendation to you. It is not a solicitation or an offer to buy or sell any security or other financial instrument. Any information including facts, opinions or quotations, may be condensed or summarised and is expressed as of the date of writing. The information may change without notice and Oakglen is under no obligation to ensure that such updates are brought to your attention. The price and value of investments and any income that might accrue could fall or rise or fluctuate. The price of shares and income from them may fall as well as rise and is not guaranteed. You may not get back the amount of your original investment. A change in the economic environment, possible changes in the law and other events may cause future performance to deviate from that expressed or implied in this document. Please note that past performance, simulations and forecasts are not a reliable guide to future returns. If an investment is denominated in a currency other than your base currency, changes in the rate of exchange may have an adverse effect on value, price or income. Investing in Packaged Retail and Insurance-based Investment Products (PRIIPs) carries a high level of risk and may not be suitable for all investors.

Any information provided by a client and used to produce this document will have been checked by Oakglen for plausibility only and the client notified accordingly of any obvious anomalies. This document and any related recommendations or strategies may not be suitable for you; you should ensure that you fully understand the potential risks and rewards and independently determine that it is suitable for you given your objectives, experience, financial resources and any other relevant circumstances. You should consult with such adviser(s) as you consider necessary to assist you in making these determinations. The opportunities and risks associated with each investment product can be found in the relevant underlying securities prospectus and any other supplementary documents. All documents will be made available at any time upon request.

Oakglen does not advise on the tax consequences of investments, and you are advised to contact a tax adviser should you have any questions in this regard. The levels and basis of taxation are dependent on individual circumstances and are subject to change. This document may relate to investments or services of an entity/person outside the United Kingdom, or to other matters which are not regulated by the Financial Conduct Authority, or in respect of which the protections of the Financial Services Compensation Scheme. Further details as to where this may be the case are available on request in respect of this document. Additionally, this document may relate to investments or services of an entity/person outside Jersey, or to other matters which are not regulated by the Jersey Financial Services Commission, or in respect of which the protections of the Jersey Financial Services Commission for retail clients. Further details as to where this may be the case are available on request in respect of this document.

This document has been prepared from sources Oakglen believes to be reliable, but we do not guarantee its accuracy or completeness and do not accept liability for any loss arising from its use. Oakglen reserves the right to remedy any errors that may be present in this document. Oakglen, its affiliates and / or their employees may have a position or holding, or other material interest or effect transactions in any securities mentioned or options thereon, or other investments related thereto and from time to time may add to or dispose of such investments.

This document is intended only for the person to whom it is issued by Oakglen. It may not be reproduced either in whole, or in part, without our written permission. The distribution of this document and the offer and sale of the investment in certain jurisdictions may be forbidden or restricted by law or regulation. This communication does not constitute the solicitation of an offer to purchase or subscribe for any investment or service in any jurisdiction where, or from any person in respect of whom, such a solicitation of an offer is unlawful.

Investments may have no public market or only a restricted secondary market. Where a secondary market exists, it is not possible to predict the price at which investments will trade in the market or whether such market will be liquid or illiquid. As such, for investments not listed or traded on any exchange, pricing information may be more difficult to obtain, and the liquidity of the investments may be adversely affected. A holder may be able to realise value prior to an investment’s maturity date only at a price in an available secondary market. The issuer of the investment may have entered into contracts with third parties to create the indicated returns and/or any applicable capital protection (in part or in full). The investment instrument's retention of value is dependent not only on the development of the value of the underlying asset, but also on the creditworthiness of the Issuer and / or Guarantor (as applicable), which may change over the term of the investment instrument. In the event of default by the issuer and/or Guarantor of the investment, and / or any third party the investment any income derived from such contracts is not guaranteed and you may get back none of, or less than, what was originally invested. Parties other than the Issuer or Guarantor (as appropriate) mentioned in this document (for instance the Lead Manager, Co-structurer, Calculation Agent or Paying Agent) do neither guarantee, repayment of the invested capital nor financial return on the investment product, if nothing is indicated to the contrary. Any capital protection given is usually an inherent part of the product; provided through the use of options, futures or other derivative products. You may have to accept smaller returns on an investment relative to a direct investment in the underlying index, basket, etc. because of the costs involved in providing the capital protection. Such capital protection normally only applies if the investment is held until maturity. The amount of initial capital to be repaid may be geared, which means that a fall in the underlying index or securities may result in a larger reduction in the amount repaid to investors. Alternative investments, derivatives or structured products are complex instruments that typically involve a high degree of risk and are intended for sale only to investors who are capable of understanding and assuming the risks involved. Structured products carry counterparty risk, in that in the event of default by the issuer you may lose some or all of your capital invested even when the product carries capital guarantees. Where this document relates to emerging markets, such investments should be made only by sophisticated investors or experienced professionals, who have independent knowledge of the relevant markets, are able to consider and weigh the various risks presented by such investments and have the financial resources necessary to bear the substantial risk of loss of investment in such investments.

The services described are provided by Oakglen or by its subsidiaries and/or affiliates in accordance with appropriate local legislation and regulation. Certain products and services may not be available in all locations or to all Oakglen clients.

Data Source: Oakglen Wealth (Jersey) Limited and Oakglen Wealth Limited, otherwise specified.

Oakglen is a registered business name of Oakglen Wealth (Jersey) Limited and Oakglen Wealth Limited.

Oakglen Wealth (Jersey) Limited is regulated in Jersey by the Jersey Financial Services Commission for the conduct of Investment Business and is a limited company with company number 121454, incorporated in Jersey on 7 June 2016. Its business address is 4th Floor, 1 IFC, St Helier, Jersey, JE2 3BX.

Oakglen Wealth Limited is authorised and regulated by the Financial Conduct Authority. The registered address of Oakglen Wealth Limited is 30 Golden Square, London, United Kingdom, W1F 9LD and is registered in England and Wales with number 13182724.